Has James Yue, MD received payments from drug or device companies?

Yes. Drug and device makers reported $1,751,329 in general payments to James Yue, MD across 672 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean James Yue, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about James Yue, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

James Yue, MD

Orthopaedic Surgery · Shelton, CTNPI 1679557615

Payments from drug & device makers

$1,751,329in general payments, 2019–2025

Across 672 payments — averaging $2606.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Aesculap AG$1.1M
Abbott$424K
Aesculap Implant Systems, LLC$69K
Medtronic$61K
Globus Medical$33K
Royal Biologics, Inc.$17K
plus $97K from 37 others

$6,680in research payments, 2019–2025

Across 5 payments — averaging $1336.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

Intrinsic Therapeutics$6K
Globus Medical$280

What the payments were for

Royalty or licence$1,092,19182%
Consulting fees$70,5145%
Speaking & faculty fees$102,4728%
Travel & lodging$47,3774%
Food & beverage$11,5111%
Gifts$210%

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Aesculap AG	26	$1,051,480
Abbott	281	$423,688
Aesculap Implant Systems, LLC	66	$68,880
Medtronic(2 entities)	49	$60,522
Globus Medical(2 entities)	69	$33,010
Royal Biologics, Inc.	27	$17,085
Spineart USA Inc	1	$14,000
Spineart SA	1	$12,000
Intrinsic Therapeutics	13	$10,400
Saluda Medical Americas, Inc.	6	$8,986
Nanofuse Biologics LLC	17	$8,246
B. Braun Medical Inc.	8	$8,066
Aesculap, Inc.	2	$8,021
Innovasis Inc	12	$8,012
Elliquence, LLC	2	$6,643
Arthrex	9	$3,504
Axiomed LLC	1	$3,000
Zimmer Biomet	9	$1,145
Alphatec Spine, Inc	1	$875
Polaris Technology Solutions LLC	4	$847
Ossdsign USA Incorporated	3	$715
Vy Spine LLC	2	$235
Amgen	24	$225
Johnson & Johnson	7	$221
Boston Scientific	2	$159
Icotec Medical Inc.	2	$154
4web, Inc.	1	$150
7d Surgical Inc.	2	$127
Vertiflex, Inc.	3	$116
Arteriocyte Medical Systems, Inc.	2	$101
Cerapedics Inc.	2	$97
Centinel Spine, LLC	2	$92
VB Spine LLC	1	$83
Providence Medical Technology, Inc.	2	$81
Si-bone, Inc.	1	$72
Spinal Simplicity, LLC	2	$63
Nalu Medical, Inc.	1	$55
Richard Wolf Medical Instruments Corp.	2	$48
Augmedics Inc.	1	$46
Surgalign Spine Technologies, Inc.	1	$37
Pacira Pharmaceuticals Incorporated	1	$20
Vertex	1	$19
Stimwave Technologies Incorporated	3	$0

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

ACTIVL$809,730
ACTIVL ARTIFICIAL DISC$317,074
PROCLAIM$92,996
Fibrinet$20,881
BARRICAID ACD (ANNULAR CLOSURE DEVICE)$10,000
Evoke SCS$8,906
RISE Intra LIF$8,423
CONTIPLEX ANESTHESIA CATHETERS$7,941
CREO MCS$6,766
RISE$6,500
Barricaid Annular Closure Device$3,600
Precision TLIF$1,625
Proclaim IPG$1,513
MazorX - Renaissance$1,435
Neuromodulation Dspsbls and Accs$1,400
RISE-L$1,300
OsseoFix$875
Mobi-C$764
AESCULAP$625
Fibricell$500

How this compares

$1,751,329 in reported general payments places this provider in the 95th percentile of 273 orthopaedic surgery providers in Connecticut.

See all orthopaedic surgery providers in Connecticut →

Medicare billing

Part B allowed, 2024

$172,255

Medicare patients

186

Services billed

784

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Pregabalin	32	$828
Gabapentin	59	$589
Lidocaine	12	$531
Tramadol Hcl	123	$456
Cyclobenzaprine Hcl	54	$328
Celecoxib	31	$312
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen	20	$183
Oxycodone Hcl	32	$153
Meloxicam	12	$88
Diazepam	17	$26

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Shelton

Monica StadeckerShelton$31K
Peter WhangNew Haven$2M
Paul SethiGreenwich$1.6M
Robert DeveneyDanbury$907K
Isaac MossFarmington$783K
James PaceFarmington$721K
John KeggiMiddlebury$380K
Sean EsmendeGlastonbury$363K
Jim HsuStamford$358K
David FrumbergNew Haven$288K

See the full list for Connecticut →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →